Search research articles
Contact Us
Filters
Showing results (1-10 of 70) with videos related to
Page
of 7
Sort By:
Viruses
|
April 16, 2014
Matrix and backstage: cellular substrates for viral vaccines
Ingo Jordan, Volker Sandig
BMC Proceedings
|
March 1, 2012
Highly efficient, chemically defined and fully scalable biphasic production of vaccine viruses
Ingo Jordan, Volker Sandig
BMC Proceedings
|
March 1, 2012
Compartmentation and channelling of metabolites in the human cell line AGE1.HN(®)
Jens Niklas, Volker Sandig, Elmar Heinzle
Cureus
|
September 30, 2022
An Orally Administered Nonpathogenic Attenuated Vaccine Virus Can Be Used to Control SARS-CoV-2 Infection: A Complementary Plan B to COVID-19 Vaccination
Tibor Bakacs, Volker Sandig, Imre Kovesdi
Pharmaceuticals (Basel, Switzerland)
|
June 1, 2023
Combination Therapy for the Treatment of Shingles with an Immunostimulatory Vaccine Virus and Acyclovir
Tibor Bakacs, Volker Sandig, Imre Kovesdi
Journal of Bioscience and Bioengineering
|
August 26, 2011
Metabolite channeling and compartmentation in the human cell line AGE1.HN determined by 13C labeling experiments and 13C metabolic flux analysis
Jens Niklas, Volker Sandig, Elmar Heinzle
Viruses
|
July 4, 2012
Authentication of the R06E fruit bat cell line
Ingo Jordan, Vincent J Munster, Volker Sandig
Virology
|
May 3, 2003
The complete nucleotide sequence, genome organization, and origin of human adenovirus type 11
Daniel Stone, Anne Furthmann, Volker Sandig, et al.
BMC Proceedings
|
March 1, 2012
Biosynthetic pathway deflection - a new cell line engineering approach
Hans Henning von Horsten, Thomas Rose, Volker Sandig
Viruses
|
January 23, 2013
A genotype of modified vaccinia Ankara (MVA) that facilitates replication in suspension cultures in chemically defined medium
Ingo Jordan, Deborah Horn, Katrin John, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 70) with videos related to
Sort By:
Page
of 7
Viruses
|
April 16, 2014
Matrix and backstage: cellular substrates for viral vaccines
Ingo Jordan, Volker Sandig
BMC Proceedings
|
March 1, 2012
Highly efficient, chemically defined and fully scalable biphasic production of vaccine viruses
Ingo Jordan, Volker Sandig
BMC Proceedings
|
March 1, 2012
Compartmentation and channelling of metabolites in the human cell line AGE1.HN(®)
Jens Niklas, Volker Sandig, Elmar Heinzle
Cureus
|
September 30, 2022
An Orally Administered Nonpathogenic Attenuated Vaccine Virus Can Be Used to Control SARS-CoV-2 Infection: A Complementary Plan B to COVID-19 Vaccination
Tibor Bakacs, Volker Sandig, Imre Kovesdi
Pharmaceuticals (Basel, Switzerland)
|
June 1, 2023
Combination Therapy for the Treatment of Shingles with an Immunostimulatory Vaccine Virus and Acyclovir
Tibor Bakacs, Volker Sandig, Imre Kovesdi
Journal of Bioscience and Bioengineering
|
August 26, 2011
Metabolite channeling and compartmentation in the human cell line AGE1.HN determined by 13C labeling experiments and 13C metabolic flux analysis
Jens Niklas, Volker Sandig, Elmar Heinzle
Viruses
|
July 4, 2012
Authentication of the R06E fruit bat cell line
Ingo Jordan, Vincent J Munster, Volker Sandig
Virology
|
May 3, 2003
The complete nucleotide sequence, genome organization, and origin of human adenovirus type 11
Daniel Stone, Anne Furthmann, Volker Sandig, et al.
BMC Proceedings
|
March 1, 2012
Biosynthetic pathway deflection - a new cell line engineering approach
Hans Henning von Horsten, Thomas Rose, Volker Sandig
Viruses
|
January 23, 2013
A genotype of modified vaccinia Ankara (MVA) that facilitates replication in suspension cultures in chemically defined medium
Ingo Jordan, Deborah Horn, Katrin John, et al.
Page
of 7